Home NDC 61958-3005-1 Sunlenca
Product NDC 61958-3005
Requested package NDC 61958-3005-1
11-digit product format 619583005
Labeler code 61958
Product ID 61958-3005_142b440e-6eae-4d76-8312-b094de1380c3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name LENACAPAVIR SODIUM
Dosage form KIT
Labeler Gilead Sciences, Inc.
Application NDA215973
Marketing category NDA
Marketing start 2025-03-18
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 5 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215973-001 SUNLENCA LENACAPAVIR SODIUM EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 N215973-001 12594267 2039-07-15 Drug product 2026-04-21 N215973-001 11944611 2041-08-28 U-3507 2024-04-23
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N215973-001 NCE 2027-12-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 3bdfa0b2c4d7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215973-001 SUNLENCA EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2022-12-22 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 120 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215973-001 12594267 2039-07-15 Drug product 2026-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215973-001 11944611 2041-08-28 U-3507 2024-04-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215973-001 12594267 2039-07-15 Drug product 2026-04-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215973-001 11944611 2041-08-28 U-3507 2024-04-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215973-001 11944611 2041-08-28 U-3507 2024-04-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215973-001 11944611 2041-08-28 U-3507 2024-04-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215973-001 11944611 2041-08-28 U-3507 2024-04-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215973-001 11944611 2041-08-28 U-3507 2024-04-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215973-001 11267799 2038-08-16 Drug substance 2023-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215973-001 11944611 2041-08-28 U-3507 2024-04-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215973-001 9951043 2034-02-28 U-3507 Drug substance, Drug product 2023-01-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215973-001 10071985 2037-08-17 Drug substance, Drug product 2023-01-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215973-001 10654827 2037-08-17 U-3507 2023-01-18 03ed91905a0d…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Sunlenca
Listing expiration 2027-12-31 Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination BDT58WJ9WE Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 10 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2625890 Internal RxNorm lookup 2625896 Internal RxNorm lookup 2625897 Internal RxNorm lookup 2625898 Internal RxNorm lookup 2625899 Internal RxNorm lookup 2625900 Internal RxNorm lookup 2625904 Internal RxNorm lookup 2625909 Internal RxNorm lookup 2625911 Internal RxNorm lookup 2625912 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61958-3005-1 Sunlenca 1 in 1 CARTON KIT 1 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61958-3005 SUNLENCA (LENACAPAVIR SODIUM) TABLET, FILM COATED SUNLENCA (LENACAPAVIR SODIUM) KIT [GILEAD SCIENCES, INC.] 7 Current NDC, 1 package rows 20250406_e5652804-29c4-40d7-aeb2-0142ed2a7b5b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 61958-3005-1 61958300501 1 KIT in 1 CARTON (61958-3005-1) * 1.5 mL in 1 VIAL (61958-3004-1) 1 kit 2025-03-18 No No Current